Skip to main content
. 2024 Jul 4;38(9):1929–1937. doi: 10.1038/s41375-024-02333-4

Fig. 3. Impact of different gene mutations on overall survival in KMT2Ar AML.

Fig. 3

A KRAS, B DNMT3A, C TP53, D comparison of patients with either KRAS-mut, DNMT3A-mut or TP53-mut and the rest of the KMT2Ar AML cohort; OS overall survival; mut mutated; wt wildtype.